Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Thompson Coburn LLP ordered by Published Date Descending.
Links to Result pages
HHS Issues Voluntary Health Care Cybersecurity Guidelines
On December 28, 2018, the U.S. Department of Health and Human Services ("HHS") published the "Health Industry Cybersecurity Practices (HICP): Managing Threats and Protecting Patients".
United States
23 Jan 2019
NY Judge Serves Up Spicy Ruling: ‘All Natural' Claims Not Preempted By Bioengineered Food Disclosure Law
In a case of first impression, a federal judge has denied a food company's efforts to lean on the doctrine of preemption to dodge a suit alleging its products were not "all natural" as labeled.
United States
30 Aug 2018
Connected Medical Device Vulnerabilities Continue To Impact Manufacturers, Health Care
Recently, Thompson Coburn's Life Sciences Decoded blog described several FDA initiatives to increase the safety and reliability of the emerging connected device market and discussed data...
United States
23 Mar 2018
FSVP Compliance Dates Arrive, Challenges To Food Industry Increase
On May 30, 2017, the FDA's Foreign Supplier Verification Programs (FSVP) for Importers of Food for Humans and Animals went into effect, placing new compliance requirements on food importers.
United States
21 Jun 2017
Privacy And The Internet Of Medical Things: What's A Curmudgeon To Do?
One of the authors of this piece uses a medical device that is wirelessly networked to the device's vendor.
United States
24 Apr 2017
Top Takeaways From 33rd Annual IAHA Annual Meeting
On Oct. 27, 2015, the Annual Meeting of the Illinois Association of Healthcare Attorneys was held at Navy Pier in Chicago. Hundreds of health care attorneys attended, including several from Thompson Coburn.
United States
10 Nov 2015
Long-Awaited Overhaul Of FDA Food Safety Rules Arrives – Part II: A Roadmap For Food Manufacturers On FDA's Changes To cGMPs
The new FDA Rule revamping cGMPs and implementing new rules referred to as HARPC will impact the food industry greatly.
United States
30 Sep 2015
Refashioning IP Asset Protection Strategies For Biotechnology And BioPharma Clients In View Of The New Legal Realities Of Subject Matter Eligibility
Congress, through three major revisions of the patent statutes, has clearly intended that biotechnological subject matter should be eligible for patenting.
United States
11 Jun 2015
A Practical Primer For Patenting Genes Amid Myriad Uncertainties
Since the courts have long held that products of nature are patentable once isolated or manipulated by man, the District Court decision of Judge Sweet in the "Myriad" case that isolated or manipulated genes are not patentable and the subsequent appeal of that decision to the Court of Appeals for the Federal Circuit (CAFC) has prompted considerable legal debate.
United States
15 Mar 2011
Links to Result pages